Pancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review
Diabetes, metabolic syndrome and obesity : targets and therapy · 2026 · Kutsyba T, Raj S, van der Berg M et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 22 20:00 ETSource: Diabetes, metabolic syndrome and obesity : targets and therapy
From the source
Read at pubmed.ncbi.nlm.nih.govPancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review
Diabetes, metabolic syndrome and obesity : targets and therapy · 2026 · Kutsyba T, Raj S, van der Berg M et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42948670/
